Synthesis and β-adrenergic activities of R-fluoronaphthyloxypropanolamine

Pharmaceutical Research

Volumn 14, Issue 4, 1997, Pages 533-536

  Adejare, Adeboye ^a   Sciberras, Sophie S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Adrenoceptor ligands; Aryloxypropanolamine; Enantioselective synthesis; Fluoroaromatic; Naphthyloxypropanolamine

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; PROPANOLAMINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOMER; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC AGENTS; ANIMALS; CEREBRAL CORTEX; NAPHTHALENES; RATS; RECEPTORS, ADRENERGIC, BETA; STEREOISOMERISM;

EID: 0030962935     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012172121453     Document Type: Article

References (21)

1. Presented in part: 211th National Meeting of the American Chemical Society, New Orleans, LA, March 1996, Abstract #MEDI 010.
2. Resnati G. and Soloshonok, V. A. Tetrahedron Symposia-in-Print Number 58, Fluoroorganic Chemistry: Synthetic Challenges and Biomedicinal Rewards, 1996.
3. Hudlicky, M. and Pavlath, A.E. Chemistry of Organic Fluorine Compounds II: A Critical Review; American Chemical Society Monograph 187, 1296 pages, 1995.
4. Schlosser, M. Tetrahedron 34:3-17, (1978).
5. Middleton, W. J. Modern Methods for Introducing Fluorine into Organic Molecules, 200th ACS National Meeting, Fluorine Division Tutorial Handout, 20 pages, Washington, DC, August 26, 1990.
6. Welch, J.T. Tetrahedron 43:3123-97.
7. Cantacuzene, D., Kirk, K. L., McCulloh, D. H., Creveling, C. R., Daly, J. W., and Kirk, K. L. Science 204:1217-9 (1979).
8. Kirk, K. L. and Creveling, C.R. Medicinal Research Reviews 4:189-220 (1984).
9. Adejare, A., Gusovsky, F., Padgett, W., Creveling, C. R. Daly, J. W. and Kirk, K. L. J. Med. Chem. 31:1972-7 (1988).
10. Clark, M. T., Adejare, A., Shams. G., Feller, D. R. and Miller, D. D. J. Med. Chem. 30::86-90 (1987).
11. Adejare, A. and Miller, D. D. J. Chem. Res. 1986, (S) 14-5.
12. Adejare, A., Nie, J., Hebel, D., Brackett, L. E., Choi, O., Gusovskly, F., Padgett, W., Daly, J. W., Creveling, C. R., and Kirk, K. L. J. Med. Chem.Res. 34:1063-8 (1991).
13. Miller, D. D., Feller, D. R., Clark, M. T., Adejare, A., Romstedt, K. J., and Shams, G. USA Patent #4737504 (1988).
14. Adejare, A. and Miller, D. D. Tetrahedron Letters25: 5597-8 (1984).
15. Stavber, S. and Zupan, M. J. Org. Chem. 50:3609-12 (1985).
16. Buu-Hoi, N. P. Xuong, N. D., and Rips, R. J. Org. Chem. 22:193-97 (1954).
17. Adcock, W., Alste, J., Rizvi, S. Q. A., and Aurangzeb, M. J. Am. Chem. Soc. 98:1701-11 (1976).
18. Gao, Y., Hanson, R. M., Klunder, J. M., Ko, S. Y., Masamune, H., and Sharpless, K. B. J. Am. Chem. Soc. 109:5765-80 (1987).
19. Klunder, J. M., Ko, S. Y., and Sharpless, K. B. J. Org. Chem. 51:3710-12 (1986).
20. Kalaria, R. N. Andorn, A. C., Tabaton, M., Whitehouse, P. J., Harik, S. I., and Unnerstall, J. R. Journal of Neurochemistry 53:1772-1781 (1989).
21. Minneman, K. P. Hegstrand, L. R., and Moliinoff, P. B. Molecular Pharmacology 16:34-36 (1979).